Quviviq is a medicine for treating adults with insomnia (difficulty sleeping) that has lasted for at least 3 months and has a considerable impact on how they function during the day. Quviviq contains the active substance daridorexant.
Therapeutic Indication
### Therapeutic indication Quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
Therapeutic Area (MeSH)
ATC Code
N05CJ03
ATC Item
daridorexant
Pharmacotherapeutic Group
Psycholeptics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| daridorexant hydrochloride | N/A | 地达西尼 |
EMA Name
Quviviq
Medicine Name
Quviviq
Aliases
N/ANo risk management plan link.
